Comparing two methods for sperm preparation in IVF
Official title: A Randomized Double-blind Controlled Study of the Cumulative Live Birth Rate of IVF Following Sperm Preparation by Microfluidic Chip Method Versus Density-gradient Centrifugation Method
Run by The University of Hong Kong · NCT06005311 · Data updated 2026-11-12
This study is testing whether a new sperm preparation method using a microfluidic chip can help infertile women under 43 have more successful pregnancies through IVF compared to the traditional method.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | Any age to 43 Years |
| Sex | All |
| Enrollment | 1136 (estimated) |
| Sponsor | The University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong, Hong Kong) |
| Status | Recruiting |
| Started | November 1, 2024 |
| Main results expected | November 30, 2027 |
| Study ends | November 30, 2029 |
| Registry record updated | December 6, 2024 |
| Trial ID | NCT06005311 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are infertile women under 43 years old who are undergoing ovarian stimulation for IVF.
✕Probably not a fit
Patients with male factor infertility requiring surgical sperm retrieval or those using donor gametes may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial aims to compare the effectiveness of a microfluidic chip method against a density-gradient centrifugation method for sperm preparation in infertile patients undergoing in-vitro fertilization (IVF). Infertile women under 43 years old will be randomly assigned to one of the two groups during ovarian stimulation for IVF at Queen Mary Hospital and Kwong Wah Hospital. The primary outcome measured will be the cumulative live birth rate within six months of randomization, with both patients and clinicians blinded to group allocation. The study seeks to determine if the microfluidic chip can improve live birth rates compared to the traditional method.
Why it matters
Potential benefit: If successful, this study could lead to higher live birth rates for patients undergoing IVF.
How similar studies have gone: While the use of microfluidic technology in reproductive medicine is promising, this specific comparison has not been widely tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Infertile women aged \<43 years at the time of ovarian stimulation for IVF Exclusion Criteria: * Women undergoing preimplantation genetic testing monogenic diseases, structural rearrangement of chromosomes or aneuploidy; * Male factor requiring surgical sperm retrieval such as microscopic epididymal sperm aspiration and testicular sperm extraction; * Use of donor oocytes and spermatozoa; * Submucosal fibroid or hydrosalpinx shown on pelvic scanning and not surgically treated; * Women who had been recruited into this study before and * Women joining other randomized trials
Where it's running
-
Department of Obstetrics and Gynaecology
Hong Kong, Hong Kong, China Recruiting
Study contacts
- Study coordinator: Yu Wing Tong, Mbbs
- Email: ptong@connect.hku.hk
- Phone: 92707722
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-assisted embryo selection on day 5 in IVF for infertility
This trial tests whether an AI-based embryo selection tool can help pick the best embryo for transfer on day 5 in IVF/ICSI to improve pregnancy chances for people with infertility.
-
Preserving sperm quality with aging through cryopreservation
This study tests whether freezing and thawing sperm can help keep younger-like DNA and molecular traits in men as they age.
-
Unstimulated Egg Retrieval with CAPA-IVM and Euploid Embryo Transfer
This study tests whether eggs can be collected without ovarian stimulation, matured in the lab, and used to create a single euploid embryo for transfer in infertility patients.
-
Ultra-Long GnRH-a Pretreatment Before Frozen Embryo Transfer for Deep Infiltrating Endometriosis
In people under 40 with deep infiltrating endometriosis and infertility, the study tests whether two injections of a GnRH agonist before hormone support improve pregnancy outcomes in their first frozen-thawed embryo transfer.
-
Endometrial Waves and Pregnancy in FET Cycles with Hormone Therapy
This study tests whether patterns of uterine contractions during hormone-prepared frozen embryo transfer affect pregnancy outcomes.
-
Environmental and lifestyle factors linked to ART success in infertility patients
This study follows 5,000 infertile men and women to see how environmental exposures and lifestyle relate to the success of assisted reproductive technology.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.